Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego (Business Wire)

Alimentiv and Dova Health Intelligence have unveiled DovaVision™, an AI-powered endoscopy reading tool for ulcerative colitis (UC) clinical trials, at Digestive Disease Week 2025. Designed to provide frame-level Mayo Endoscopic Sub-score (MES) analysis, DovaVision enables deeper, quantitative insights into disease severity using anonymized IBD colonoscopy video data. Integrated into Alimentiv’s Notō™ platform, the tool offers researchers and sponsors enhanced image interpretation, more consistent scoring, and data correlation with patient outcomes. Though not intended for clinical diagnosis, DovaVision represents a major step toward precision, AI-driven gastrointestinal research.